Logo
x

Search category

Subscribe Now

Multi-Year

BARDA Signs a Multi-Year Agreement with Regeneron for its REGN-EB3 for National Preparedness

BARDA Signs a Multi-Year Agreement with Regeneron for its REGN-EB3 for National Preparedness

  • July 30, 2020
AbCellera Signs an Exclusive Multi-Year Agreement with Eli Lilly to Develop Abs for up to Nine Targets

AbCellera Signs an Exclusive Multi-Year Agreement with Eli Lilly to Develop Abs for up to Nine Targets

  • May 25, 2020
Takeda Signs a Multi-Year Research Collaboration with Evotec to Expedite Research Program Across its Core Therapeutic Areas

Takeda Signs a Multi-Year Research Collaboration with Evotec to Expedite Research Program Across its Core Therapeutic Areas

  • April 6, 2020
Mount Sinai Signs a Multi-Year Collaboration with Harbour BioMed to Develop Novel Biotherapies for Multiple Cancer Indications and COVID-19

Mount Sinai Signs a Multi-Year Collaboration with Harbour BioMed to Develop Novel Biotherapies for Multiple Cancer Indications and...

  • March 6, 2020
Veracyte Signs a Multi-Year Agreement with AstraZeneca

Veracyte Signs a Multi-Year Agreement with AstraZeneca

  • January 9, 2020
Arena Signs a Multi-Year Agreement with Beacon Discovery to Develop Therapies for Immune and Inflammatory Diseases

Arena Signs a Multi-Year Agreement with Beacon Discovery to Develop Therapies for Immune and Inflammatory Diseases

  • January 3, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.